Hot Sale CAS 82640-04-8 Raloxifen Hydrochloride

• Customization: Available
• Powder: Yes
• Customized: Non-Customized
• Model NO.: HCL
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Solid
• Purity: >99%
• Color: White
• OEM: Yes
• MW: 510.04
• Melting Point: 250-253c
• Transport Package: Bag
• Specification: standard
• Trademark: qsc
• Origin: China
• Production Capacity: 50000000

Product Description

Product Description

Product Name	Ralo xifene HCL
Appearance	White powder
Assay	99%min, 98.0% --101.0%
Test	HPLC
Certificate	ISO 9001
CAS	82640-04-8
MF	C28H28ClNO4S
Storage Temperature	Cool Dry Place

 

Raloxi fene HCL is an oral selective estrogen receptor modulator (SERM) that has estrogenic actions on bone and anti-estrogenic actions on the uterus and breast. It is used in the prevention of osteoporosis in postmenopausal women.
 

Fuction of Raloxi fene HCL

It is used to prevent and treat osteoporosis (condition in which the bones become thin and weak and break easily) in women who have undergone menopause (change of life; end of menstrual periods). 

It is also used to decrease the risk of developing invasive breast cancer (breast cancer that has spread outside of the milk ducts or lobules into the surrounding breast tissue) in women who are at high risk of developing this type of cancer or who have osteoporosis. 

It cannot be used to treat invasive breast cancer or to prevent invasive breast cancer from coming back in women who have already had the condition. 

It also cannot be used to decrease the risk of developing non-invasive breast cancer. It is in a class of medications called selective estrogen receptor modulators (SERMs). It prevents and treats osteoporosis by mimicking the effects of estrogen (a female hormone produced by the body) to increase the density (thickness) of bone. 

It decreases the risk of developing invasive breast cancer by blocking the effects of estrogen on breast tissue. 

It may stop the development of tumors that need estrogen to grow.

It is an active pharmaceutical ingredient used to prevent osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast cancer.